It is also important to note that advancements in the management of CF and CFrLD have occurred in parallel with the introduction of CFTR modulators, which include improved nutritional support, antibiotic use, pulmonary care, recognition and management of liver disease, and developments in immunosuppressant protocols.4 The gene discussed is CFTR; the disease is liver disorder.